ICU Medical (ICUI) saw its shares rise over 10% on the day.
Haemonetics (HAE) saw its shares rise nearly 10% on the day after the company reported better-than-expected second quarter and first Half Fiscal 2018 results.
Abbott Laboratories (ABT) has agreed to divest two medical device businesses in order to settle Federal Trade Commission (FTC) charges in relation to its proposed acquisition of St. Jude Medical (STJ).
Abbott Labs (ABT) reported third-quarter 2016 earnings of 59 cents per share, beating the Zacks Consensus Estimate of a loss of 58 cents.
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
HONG KONG (AP) — Japanese stocks posted their biggest gain in nearly seven years Wednesday, leading other world indexes higher, as Asian officials sought to counter pessimism about prospects for markets and economic growth. Japan's Nikkei 225 index vaulted 7.7 percent to 18,770.51, its biggest one-day rise since October 2008, when markets were volatile during the global financial crisis, and its 10th biggest gain since 1949. Other major Asian markets rose between 2 and 4 percent. The strong gains come after three months of weakness in stock markets that was partly sparked by the dramatic sell-off in Chinese shares beginning in early June. Economic policy measures in China and Japan were positives for investors on Wednesday but there were also technical factors at work in the rebound, analysts said. "Buoyant sentiments were in full display across Asia as regional bourses flashed green," said Bernard Aw, market strategist at IG in Singapore. "Risk is back in vogue and the European traders clearly embrace it as well," he said in market commentary. European markets rose strongly in early trading. France's CAC 40 added 2.1 percent to 4,659.01 and Germany's DAX gained 1.7 percent to 10,447.69. Britain's FTSE 100 rose 1.8 percent to 6,255.42. U.S. stocks were poised to open higher a day after posting their second biggest gains of the year. Dow futures were up 1.1 percent to 16,638.00. Broader S&P 500 futures rose 1 percent to 1,986.10. The Nikkei, which had earlier hit its lowest level since February, bounced after comments from Prime Minister Shinzo Abe that raised expectations of more measures to shore up economic growth under his "Abenomics" stimulus program. The remarks gave an extra boost to Japanese stocks, which some analysts said were lagging behind the recovery this week on Wall Street and other global markets. "The markets overnight looked much healthier while the Nikkei was still pointing in the wrong direction," said Ben Collett, head of Japan and Asian equities at Sunrise Brokers in Hong Kong. "The unsexy truth is that this is a lot of people moving to buy stock and not many sellers." In written remarks from Abe read to a Bank of America-Merrill Lynch conference in Tokyo, the prime minister pledged to cut corporate tax rates by at least 3.3 percentage points next year. Passage of legislation making it easier to hire temporary workers and reports that Abe plans to keep his current economic team in a cabinet reshuffle next month also appeared to whet investor appetite. China's Ministry of Finance helped with a new round of measures to revive growth. The steps, which include infrastructure spending and reforming taxes for small businesses, follow other recent moves aimed at soothing jittery markets. A rebound in Shanghai shares Tuesday also reinforced faith in Beijing's interventionist policies to halt sliding prices. Other Asian benchmarks ended with big gains. South Korea's Kospi added 3 percent to 1,934.20 and Hong Kong's Hang Seng climbed 4.1 percent to 22,131.31. The Shanghai Composite Index in mainland China rose 2.3 percent to 3,243.09. Australia's S&P/ASX 200 gained 2.1 percent to 5,221.10. Some analysts said short-covering by traders, or buying shares to close out short positions taken on expectations a stock price will drop, was another factor behind the rally. Gains were spread across sectors in Tokyo: medical technology company Terumo Corp. led with an 11.6 percent jump, toilet maker Toto Corp. soared 10.5 percent and Fuji Heavy Industries gained 9.2 percent. In energy markets, U.S. benchmark oil was down 5 cents to $45.89 a barrel in electronic trading on the New York Mercantile Exchange. The contract fell 11 cents to close at $45.94 a barrel in New York on Tuesday. Brent Crude, a benchmark for international oils used by many U.S. refineries, rose 17 cents to $49.69 in London. The dollar rose to 120.53 yen from 119.99 yen on Tuesday. The euro slipped to $1.1193 from $1.1214. ___ AP Business Writer Elaine Kurtenbach in Tokyo contributed. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.
Japan stocks were higher after the close on Wednesday, as gains in the Non-Metal Minerals, Fishery and Precision Instruments sectors led shares higher. At the close in Tokyo, the Nikkei 225 added 0.46%. The best performers of the session on the Nikkei 225 were Nippon Suisan Kaisha, Ltd. (TOKYO:1332), which rose 18.57% or 70.0 points to trade at 447.0 at the close. Meanwhile, Terumo Corp. (TOKYO:4543) added 12.94% or 405.0 points to end at 3535.0 and Kajima Corp. (TOKYO:1812) was up 6.77% or 44.0 points to 694.0 in late trade. The worst performers of the session were Marui Group Co., Ltd. (TOKYO:8252), which fell 10.98% or 195.0 points to trade at 1581.0 at the close. Minebea Co., Ltd. (TOKYO:6479) declined 6.28% or 126.0 points to end at 1880.0 and IHI Corp. (TOKYO:7013) was down 5.63% or 26.0 points to 436.0. Rising stocks outnumbered declining ones on the Tokyo Stock Exchange by 1125 to 752. Shares in Nippon Suisan Kaisha, Ltd. (TOKYO:1332) rose to 3-years highs; rising 18.57% or 70.0 to 447.0. Shares in Terumo Corp. (TOKYO:4543) rose to 52-week highs; up 12.94% or 405.0 to 3535.0. Shares in Kajima Corp. (TOKYO:1812) rose to 3-years highs; rising 6.77% or 44.0 to 694.0. Shares in IHI Corp. (TOKYO:7013) fell to 52-week lows; down 5.63% or 26.0 to 436.0. The Nikkei Volatility, which measures the implied volatility of Nikkei 225 options, was down 0.63% to 17.34. Crude oil for September delivery was up 1.15% or 0.53 to $46.27 a barrel. Elsewhere in commodities trading, Brent oil for delivery in September rose 1.22% or 0.61 to hit $50.60 a barrel, while the December Gold contract fell 0.34% or 3.70 to trade at $1087.00 a troy ounce. USD/JPY was down 0.00% to 124.38, while EUR/JPY fell 0.10% to 135.21. The US Dollar Index was up 0.13% at 98.17.
Врачи города Шахтерск, где на данный момент идут бои взывают о помощи. В данный момент они остро нуждаются в контейнерах для сборки и перевозки крови Производитель:TERUMO Консервант:CPDA-1 Модификация:2-камерный или 1 - камерный Объем крови:350 (400, 450) мл Пластиковые контейнеры для крови с антикоагулянтом CPDA-1 350/300 представляют собой закрытую систему для сбора крови и последующего разделения на компоненты (эритроцитная масса, плазма). Они также пригодны для хранения, как цельной крови, так и компонентов, получаемых из неё.
Thoratec Corp. revealed that it has taken over the DuraHeart II (DH-II) ventricular assist system from Terumo Corporation.
BSD Medical ([[BSDM]] +21%) gets a big boost today on the heels of it's announcement of a long term, exclusive deal with Tokyo's Terumo ([[TRUMF.PK]]) Europe to provide its MicroThermX ablation system to 100 countries in Europe, Western Asia and North Africa. The agreement opens a potential $1B+ market for MicroThermX, which is used to treat a variety of cancers.
BSD Medical (BSDM +21%) gets a big boost today on the heels of it's announcement of a long term, exclusive deal with Tokyo's Terumo (TRUMF.PK) Europe to provide its MicroThermX ablation system to 100 countries in Europe, Western Asia and North Africa. The agreement opens a potential $1B+ market for MicroThermX, which is used to treat a variety of cancers. Post your comment!
Спайдер торгуется на премаркете около уровня сопротивления 155.50. Европейские индексы на положительной территории. Nikkei +2,8 % SPY (внутридневной график) рост на премаркете. Сопротивление 155.50-156.00 Поддержка: 154.75 – 154.00 Ожидаемая макроэкономическая статистика: • Нет значимых событий Премаркет NYSE/NASDAQ: • Gapping up • In reaction to strong earnings/guidance: AZZ +0.4%. • • M&A news: LUFK +37.3% (Lufkin Industries confirms it will be acquired by GE for $3.3 bln or $88.50/share in cash). • • Select oil/gas related names showing strength boosted by LUFK news: WFT +2.2%, NBR +2%, OXY +1.1%. • • Other news: BCRX +23.5% and NVAX +5% (more reports of China bird flu deaths), BSDM +7.8% (announces exclusive multi-million dollar distribution agreement with Terumo Europe NV), TSL +6.4% (Trina Solar Chairman says company plans to return to profit in the second half of 2013, according to reports), AMRN +3.6% (announces new clinical data showing significant reductions in Apolipoprotein C-III levels in MARINE and ANCHOR Studies of Vascepa; Amarin's MARINE and ANCHOR trials, the 4 gram dose of Vascepa achieved reductions), CLF +3.5% (Barron's profiles positive view on Cliffs Natural Resources (CLF); mentions that company could become takeover target of valuation falls), STZ +3.3% (Constellation Brands has reached an agreement with DoJ; Parties request extension of the present stay of proceedings until April 23, 2013 to finalize proposed consent judgment), CYMI +2.3% (Cymer: U.S. Department of Justice clears ASML acquisition of Cymer), SRPT +1.9% (still checking), BUD +1.6% (Constellation Brands has reached an agreement with DoJ; Parties request extension of the present stay of proceedings until April 23, 2013 to finalize proposed consent judgment), AAPL +1.2% (still checking for anything specific), JPM +0.4% ( Dealbook discusss that JPM is working to prevent spilt of Chairman and CEO positions). • • Analyst comments: RDN +2.5% (upgraded to Outperform from Neutral at Macquarie),-F and si WLL +2.1% (upgraded to Overweight from Neutral at JP Morgan), JNPR +2% (hearing upgraded to Buy from Hold at Argus), PERI +1.8% (initiated with a Buy at Needham based on strong product pipeline & valuation; tgt $14), NVS +0.9% (upgraded to Neutral from Underperform at BofA/Merril ) • Gapping down M&A news: OMPI -5.6% (Merz Pharma Group Withdraws Proposal to Acquire OMPI). Select financial related names showing weakness: ING -1.4%, CS -1.3%, UBS -1.2%, HBC -0.6%. Other news: CEDC -25% (won creditor approval of proposed restructuring plan), NBG -16.7% (following WSJ.com report suggesting Greek merger stopped), DCTH -6.2% (receives notification of PDUFA date extension), BYI -5% (still checking), YUM -0.7% (following news of new Chinese bird flu outbreak). Analyst comments: JNJ -0.7% (downgraded to Neutral from Overweight at JP Morgan) Торговые идеи NYSE и NASDAQ: BBY – акция показывала силу в течении 2х дней. На премаркете торгуется у уровня сопротивления. Выше 25.50 смотрим акцию в лонг. STZ – малообъемный премаркет, смотрим акцию в лонг выше 49.50. BCRX – рост на новостях об эпидемии птичьего гриппа в Китае. Выше 2.00 смотрим акцию в лонг, ниже – шорт с потенциалом 25 центов. YUM – шорт ниже 66.00 с потенциалом доллар и выше. Акция может быть волатильна на новостях об эпидемии в Китае. Оригинал статьи: shark-traders.com/blog/analitika-na-08-04/
Cadence Pharmaceutical ([[CADX]] +2%) moves up after beating Q4 estimates across the board. Total revenue rose over 180% Y/Y, driven by higher licensing revenue driven by it's data license agreement with Terumo Corporation. Terumo intends to seek regulatory approval in Japan for the same intravenous formulation of acetaminophen as [[CADX]]'s Ofirmev.
Cadence Pharmaceutical (CADX +2%) moves up after beating Q4 estimates across the board. Total revenue rose over 180% Y/Y, driven by higher licensing revenue driven by it's data license agreement with Terumo Corporation. Terumo intends to seek regulatory approval in Japan for the same intravenous formulation of acetaminophen as CADX's Ofirmev. 1 comment!
Ведущий производитель медицинского оборудования в Японии компания Terumo сделала предложение Olympus о слиянии...
Olympus (OCPNY.PK) is continuing discussions with Sony (SNE), Terumo and Fujifilm about possible capital-boosting tie-ups, with a "50-50" chance that Olympus will choose Sony, according to Chairman Yasuyuki Kimoto.
Olympus (OCPNY.PK) is continuing discussions with Sony (SNE), Terumo and Fujifilm about possible capital-boosting tie-ups, with a "50-50" chance that Olympus will choose Sony, according to Chairman Yasuyuki Kimoto. Post your comment!